Research programme: biologics - Navya Biologicals

Drug Profile

Research programme: biologics - Navya Biologicals

Alternative Names: NAV 002; NAV 003; NAV 004; NAV 005; NAV 007; NAV 008; NAV 009; NAV 010; NAV 012; NAV 013

Latest Information Update: 29 Nov 2016

Price : $50

At a glance

  • Originator Navya Biologicals
  • Class Biological peptides; Biological proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Autoimmune disorders; Inflammatory bowel diseases; Renal failure; Unspecified
  • Research Age-related macular degeneration; Cancer; Infertility; Myocardial infarction

Most Recent Events

  • 25 Nov 2016 Early research in Age-related macular degeneration in India (unspecified route)
  • 25 Nov 2016 Early research in Cancer in India (unspecified route)
  • 25 Nov 2016 Early research in Infertility in India (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top